CompletedNot Applicable

ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study

United States300 participantsStarted 2022-02-14

Plain-language summary

The primary purpose of this study is to assess the best method for encouraging high-risk cancer survivors to get screened for colorectal cancer at the recommended age.

Who can participate

Age range30 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Eligible participants will include people who: * Enrolled on the Childhood Cancer Survivor Study * Were treated with radiation to the abdomen, pelvis, spine, or total body irradiation * Have no history of colorectal cancer * Have not had a colonoscopy in the last 5 years or Cologuard in the last 3 years * Have a smartphone Exclusion Criteria: * Do not reside in the United States * Do not speak English

What they're measuring

Proportion of patients who report completing a colonoscopy or Cologuard test (Cologuard test plus colonoscopy if Cologuard is positive) within 12 months of randomization

Timeframe: 12 months

Trial details

NCT IDNCT05084833

SponsorAnn & Robert H Lurie Children's Hospital of Chicago

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-30

View on ClinicalTrials.gov More Colorectal Cancer trials